Physiologically assessed collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease.
Lambiase
P
P
Edwards
R
R
Bucknall
C A
CA
Marber
M S
MS
D000925:Anticoagulants / Q000008:administration & dosage; D003097:Collateral Circulation; D003327:Coronary Disease / Q000097:blood / Q000503:physiopathology*; D003331:Coronary Vessels / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D016228:Endothelial Growth Factors / Q000097:blood; D016222:Fibroblast Growth Factor 2 / Q000097:blood; D006133:Growth Substances / Q000097:blood*; D006493:Heparin / Q000008:administration & dosage; D006801:Humans
D000925:Anticoagulants; D016228:Endothelial Growth Factors; D006133:Growth Substances; D016222:Fibroblast Growth Factor 2; D006493:Heparin